ERBB2 and breast cancer: Although there are manifold phenotypes of this disease, approximately 15–20% of breast cancer cases present an overexpression of the human epidermal growth factor receptor-2 (HER2) [3,4], which in addition is also overexpressed in other types of solid tumors [5].